Galit Frydman Discusses JTH Research on Cerebral Vein Thrombosis Risk from Hormonal Contraceptives
Galit Frydman, Founder and Chief Scientific Officer of Coagulo Medical Technologies, Inc., reposted from Journal of Thrombosis and Haemostasis (JTH) on LinkedIn:
“Yet another example of how femtech needs more attention. Hormonal birth control is such a popular form of birth control, yet it can pose life-threatening adverse events to the woman using it.
I never realized how much women’s, maternal and fetal medicine was behind until I had my own pregnancy and child.
The market size is not a question here….why is funding and why are companies so far behind on these issues? (lots of reasons for this! but I thought it would start an interesting conversation on this platform)”
Journal of Thrombosis and Haemostasis (JTH) has shared a post on LinkedIn:
“The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
In this case-control study of 206 women with CVT and 868 controls, combined hormonal contraceptive (CHC) use was associated with a 10-fold higher risk of CVT. Risk increased with higher estrogen doses and was particularly elevated with fourth-generation pills (OR 28.3). Progestin-only and variable-dose CHCs carried a 6-fold increased risk. Importantly, thrombophilia and positive family history had synergistic effects, with odds ratios exceeding 200 in some subgroups.”
Title: The risk of cerebral vein thrombosis associated with different types of combined hormonal contraceptives: a case-control study
Authors: Maria Abbattista, Addolorata Truma, Ida Martinelli, Francesca Gianniello, Serena M. Passamonti, Marco Capecchi, Andrea Artoni, Flora Peyvandi, Paolo Bucciarelli

Read the full article here.
Stay updated with Hemostasis Today.
-
Feb 26, 2026, 15:58Daniel Victor Ortigoza։ Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Women
-
Feb 26, 2026, 15:51Augustina Isioma Ikusemoro: The Real Miracle in Trauma Care Happens Behind the Scenes
-
Feb 26, 2026, 15:42Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
-
Feb 26, 2026, 15:40Elvira Grandone: ISTH Launches An International Survey to Capture Real-World Practice of Pregnancy Anemia
-
Feb 26, 2026, 15:39Ashok Yadav: Placental Glycogen as a Vital Energy Reserve for Fetal and Placental Health
-
Feb 26, 2026, 15:37Nayab Ahmed: Main Reasons for Washing Platelet-Rich Plasma
-
Feb 26, 2026, 15:36Robert Negrin Shares His Outlook for the Year Ahead as ASH President
-
Feb 26, 2026, 15:24Nancy Shapiro: Excited to See This Publication on Current Landscape of Anticoagulation Stewardship Released
-
Feb 26, 2026, 15:15Ahmed Nasreldein: Stay Current on Key Updates in Ischemic and Hemorrhagic Stroke